429 related articles for article (PubMed ID: 29593036)
1. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
[TBL] [Abstract][Full Text] [Related]
2. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
[TBL] [Abstract][Full Text] [Related]
3. H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M158-66-Specific CD8+ T Cells.
van de Sandt CE; Sagong KA; Pronk MR; Bestebroer TM; Spronken MI; Koopmans MPG; Fouchier RAM; Rimmelzwaan GF
J Infect Dis; 2018 Jul; 218(4):581-585. PubMed ID: 29659927
[TBL] [Abstract][Full Text] [Related]
4. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
[TBL] [Abstract][Full Text] [Related]
5. Positive Selection in CD8+ T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages.
Machkovech HM; Bedford T; Suchard MA; Bloom JD
J Virol; 2015 Nov; 89(22):11275-83. PubMed ID: 26311880
[TBL] [Abstract][Full Text] [Related]
6. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
7. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
[TBL] [Abstract][Full Text] [Related]
8. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
[TBL] [Abstract][Full Text] [Related]
9. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.
Valkenburg SA; Josephs TM; Clemens EB; Grant EJ; Nguyen TH; Wang GC; Price DA; Miller A; Tong SY; Thomas PG; Doherty PC; Rossjohn J; Gras S; Kedzierska K
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4440-5. PubMed ID: 27036003
[TBL] [Abstract][Full Text] [Related]
11. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
[TBL] [Abstract][Full Text] [Related]
12. Influenza A virus matrix protein 1-specific human CD8+ T-cell response induced in trivalent inactivated vaccine recipients.
Terajima M; Cruz J; Leporati AM; Orphin L; Babon JA; Co MD; Pazoles P; Jameson J; Ennis FA
J Virol; 2008 Sep; 82(18):9283-7. PubMed ID: 18614638
[TBL] [Abstract][Full Text] [Related]
13. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.
Ichihashi T; Yoshida R; Sugimoto C; Takada A; Kajino K
PLoS One; 2011; 6(9):e24626. PubMed ID: 21949735
[TBL] [Abstract][Full Text] [Related]
14. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
[TBL] [Abstract][Full Text] [Related]
15. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
Rimmelzwaan GF; Kreijtz JH; Bodewes R; Fouchier RA; Osterhaus AD
Vaccine; 2009 Oct; 27(45):6363-5. PubMed ID: 19840674
[TBL] [Abstract][Full Text] [Related]
16. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.
Lee LY; Ha do LA; Simmons C; de Jong MD; Chau NV; Schumacher R; Peng YC; McMichael AJ; Farrar JJ; Smith GL; Townsend AR; Askonas BA; Rowland-Jones S; Dong T
J Clin Invest; 2008 Oct; 118(10):3478-90. PubMed ID: 18802496
[TBL] [Abstract][Full Text] [Related]
17. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
[TBL] [Abstract][Full Text] [Related]
18. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
[TBL] [Abstract][Full Text] [Related]
19. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
van de Sandt CE; Kreijtz JH; de Mutsert G; Geelhoed-Mieras MM; Hillaire ML; Vogelzang-van Trierum SE; Osterhaus AD; Fouchier RA; Rimmelzwaan GF
J Virol; 2014 Feb; 88(3):1684-93. PubMed ID: 24257602
[TBL] [Abstract][Full Text] [Related]
20. HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8+ T cells.
Sant S; Quiñones-Parra SM; Koutsakos M; Grant EJ; Loudovaris T; Mannering SI; Crowe J; van de Sandt CE; Rimmelzwaan GF; Rossjohn J; Gras S; Loh L; Nguyen THO; Kedzierska K
PLoS Pathog; 2020 Aug; 16(8):e1008714. PubMed ID: 32750095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
